You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
君實生物(688180.SH):與微境生物簽署技術轉讓及合作協議 公司獲得微境生物研發的四款藥物項目50%權益
格隆匯 09-16 18:05

格隆匯 9 月 16日丨君實生物(688180.SH)公佈,近日,公司與微境生物醫藥科技(上海)有限公司(以下簡稱“微境生物”)簽署了《技術轉讓及合作協議》(以下簡稱“《協議》”),微境生物將其研發的四款藥物項目代號分別為WJ1024/WJ1075(以公司最終選定的其中之一為準)、WJ05129、APL1898、WJ13404的50%權益轉讓給公司,公司將獲得上述藥物在全球範圍內的獨家生產權、委託生產權及銷售權。

本次合作未構成關聯交易,亦不構成《上市公司重大資產重組管理辦法》規定的重大資產重組。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account